No Data
No Data
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PDF Version CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 19, 2024-- Seres Therapeutics, Inc. (Nasdaq: MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that
11 Oversold NASDAQ Stocks To Buy Right Now
11 Oversold Healthcare Stocks To Buy Right Now
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Morgan Sta
Oppenheimer Sticks to Its Buy Rating for Seres Therapeutics (MCRB)
loading...
No Data
leew1966 : what is this app. ty
PinkiiiOP leew1966: It’s from moomoo only, information regarding transactions for my trading investments. When u r writing ur post, chk various symbols; u will find the details there.
wooper : why